Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Journal of Vascular and Interventional Radiology : JVIR|December 3, 2014
S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomesWilliam A Gray, Andrew Feiring, Marco Cioppi, et al.Journal of the American College of Cardiology|January 30, 2007
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trialMarco Valgimigli, Keith Dawkins, Carlos Macaya, et al.The American Journal of Cardiology|May 21, 2008
Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II)Ahmed A Khattab, Joost Daemen, Gert Richardt, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 9, 2021
Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III studyFranz R Eberli, Hans-Peter Stoll, Philip Urban, et al.The New England Journal of Medicine|September 15, 2006
Sirolimus-eluting versus uncoated stents in acute myocardial infarctionChristian Spaulding, Patrick Henry, Emmanuel Teiger, et al.Journal of the American College of Cardiology|February 23, 2010
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesionsPatrick W Serruys, Yoshinobu Onuma, Scot Garg, et al.Revista Espanola De Cardiologia (English Ed.)|September 30, 2019
Impact of vascular access on outcome after PCI in patients at high bleeding risk: a pre-specified sub-analysis of the LEADERS FREE trialVíctor Alfonso Jiménez Díaz, Thomas Hovasse, Andrés Íñiguez, et al.European Heart Journal|February 3, 2007
The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II)Keiichi Tsuchida, Antonio Colombo, Thierry Lefèvre, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 17, 2009
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS IISophia Vaina, Vassilis Voudris, Marie-Claude Morice, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2020
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patientsGuillaume Marquis-Gravel, Philip Urban, Samuel Copt, et al.Pageof 8